About the Myositis Working Group

Idiopathic inflammatory myopathies (IIM) are rare inflammatory autoimmune diseases, commonly with primary involvement of the skeletal muscle. IIM are multi-system diseases often extending beyond muscle weakness and may involve the lungs, joints, skin, and the gastrointestinal tract.

The aim of the Outcome Measures in Rheumatology (OMERACT) Myositis group is to identify core domains and instruments that reflect the life impact area in IIM, with strong patient participation.

Helene Alexanderson

Helene Alexanderson

Co-Chair

Lisa Christopher-Stine

Lisa Christopher-Stine

Co-Chair

Jin Park

Co-Chair

chris mecoli

Chris Mecoli

Fellow

Screen Shot 2021-02-23 at 9.20.11 AM

Ingrid de Groot

Patient Research Partner

Screen Shot 2021-09-13 at 5.47.22 PM

Catherine Sarver

Patient Research Partner

OMERACT Endorsed Core Domain Core Domain Set for use in Clinical Trials/LOS in Myositis

Screen Shot 2021-02-23 at 9.14.32 AM

Working Group Members:

Lisa Christopher-Stine
Helene Alexanderson
Yeong-Wook Song
Ingrid de Groot
Catherine Sarver
Christopher Mecoli
Bing Bingham
Dorcas Beaton
Lara Maxwell
Ingrid Lundberg
Malin Regardt
Marianne de Visser
Merrilee Needham
Jin Park
Dana DiRenzo

Scroll to Top